At a glance

ClinicalIndex Comparison Record

N/ACompleted· 58 enrolled

Drug / intervention

Ginseng +1 moredietary

Likely dose

Not stated in record

Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02796664

NCT02796664N/ACompleted

Compare CT.gov

Preventive Effects of Ginseng Against Atherosclerosis and Subsequent Ischemic Stroke: A Randomized Controlled Trial

Dae Chul Suh·interventional·Posted Jun 13, 2016·Updated Aug 24, 2021

In Brief

A clinical study evaluating Ginseng and Placebo for Ischemic Stroke and Atherosclerosis. Completed, enrolled 58 participants across 1 site.

Detailed Summary

This study is a 12-month, double-blind, randomized, placebo-controlled trial. The purpose of this study is to determine whether ginseng is effective in the prevention of atherosclerosis and subsequent ischemic stroke. High-risk patients with severe atherosclerosis in the major intracranial arteries and extracranial carotid artery were enrolled.

Study Details

Study Typeinterventional

Allocation--

Masking--

Primary Purpose--

ConditionsIschemic Stroke, Atherosclerosis

CountriesSouth Korea

CollaboratorsKorea Ginseng Corporation

Timeline

N/ACompletedFinished

2017201820192020202120222023202420252026

First PostedJun 2016

Enrollment StartJun 2016

Primary CompletionJul 2018

TodayJul 2026

First PostedJun 13, 2016

Enrollment StartJun 23, 2016

Primary CompletionJul 4, 2018

TodayJul 2, 2026

Enrollment to primary: 2.0 yearsPosted 10.1 years ago

Interventions

Ginsengdietary

Korean Red Ginseng extract tablet (0.5 grams/tablet, 2 tablets twice a day) daily for 12 months.

Placebodietary

Placebo (0.5 grams/tablet, 2 tablets twice a day) daily for 12 months.